Eiko LifeSciences Limited (BOM:540204)

Eiko LifeSciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	411.42	376.64	279.29	183.21	254.12	119.91
Other Revenue	-0	-0	-	-	-	-
Revenue	411.42	376.64	279.29	183.21	254.12	119.91
Revenue Growth (YoY)	21.31%	34.85%	52.44%	-27.90%	111.93%	15.18%
Cost of Revenue	327.05	328.05	254.16	161.14	226.16	106.26
Gross Profit	84.37	48.59	25.14	22.07	27.96	13.65
Selling, General & Admin	8.65	7.23	2.73	3.68	2.82	1.23
Other Operating Expenses	23.49	13.76	6.28	8.85	11.98	6.68
Operating Expenses	41.32	28.36	15.63	18.85	20.42	8.52
Operating Income	43.05	20.23	9.5	3.22	7.53	5.12
Interest Expense	-2.36	-1.53	-1.42	-1.5	-3.69	-0.88
Interest & Investment Income	6.93	6.93	1.82	7.27	6.42	3.58
Earnings From Equity Investments	1.94	1.43	-	-	-	-
Currency Exchange Gain (Loss)	0.03	0.03	-0.06	0.96	0.11	0.5
Other Non Operating Income (Expenses)	1.27	-0.06	-0	0	-0.95	-
EBT Excluding Unusual Items	50.86	27.04	9.84	9.95	9.42	8.33
Gain (Loss) on Sale of Investments	0.2	0.2	-	0.32	-	-
Gain (Loss) on Sale of Assets	0	0	-	-	-	-
Other Unusual Items	2.93	3.41	-	-	-	-
Pretax Income	54	30.65	9.84	10.26	9.42	8.33
Income Tax Expense	13.32	7.46	2.33	2.58	2.36	2.18
Earnings From Continuing Operations	40.68	23.19	7.52	7.69	7.06	6.14
Minority Interest in Earnings	-6.25	-2.13	-	-	-	-
Net Income	34.43	21.06	7.52	7.69	7.06	6.14
Net Income to Common	34.43	21.06	7.52	7.69	7.06	6.14
Net Income Growth	186.07%	180.20%	-2.25%	8.94%	14.88%	-
Shares Outstanding (Basic)	13	13	10	10	8	4
Shares Outstanding (Diluted)	13	13	10	10	8	4
Shares Change (YoY)	15.43%	26.37%	5.41%	25.30%	104.48%	-
EPS (Basic)	2.55	1.62	0.73	0.79	0.90	1.61
EPS (Diluted)	2.55	1.62	0.73	0.79	0.90	1.61
EPS Growth	147.83%	121.73%	-7.26%	-12.72%	-44.03%	-
Free Cash Flow	6.43	-73.67	-74.26	39.99	-78.82	-8.25
Free Cash Flow Per Share	0.48	-5.65	-7.20	4.09	-10.09	-2.16
Gross Margin	20.51%	12.90%	9.00%	12.05%	11.00%	11.38%
Operating Margin	10.46%	5.37%	3.40%	1.76%	2.96%	4.27%
Profit Margin	8.37%	5.59%	2.69%	4.20%	2.78%	5.12%
Free Cash Flow Margin	1.56%	-19.56%	-26.59%	21.83%	-31.02%	-6.88%
EBITDA	52.5	27.6	16.13	9.55	13.16	5.74
EBITDA Margin	12.76%	7.33%	5.78%	5.21%	5.18%	4.78%
D&A For EBITDA	9.45	7.37	6.63	6.33	5.62	0.62
EBIT	43.05	20.23	9.5	3.22	7.53	5.12
EBIT Margin	10.46%	5.37%	3.40%	1.76%	2.96%	4.27%
Effective Tax Rate	24.66%	24.35%	23.64%	25.09%	25.09%	26.23%
Revenue as Reported	419.91	383.8	281.05	191.76	260.85	124.51
Advertising Expenses	-	0.06	0.1	0.06	0.05	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.